Haemonetics Corp (HAE)
25.70 x 2 72.00 x 1
Pre-market by (Cboe BZX)
64.25 +0.90 (+1.42%) 03/26/25 [NYSE]
25.70 x 2 72.00 x 1
Pre-market 64.25 unch (unch) 19:00 ET
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select FieldsSymbol | HAE | ICUI | NVST | ||
Company | Haemonetics Corp | I C U Medical Inc | Envista Holdings Corp | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NYSE | ||
Open | 63.31 | 148.93 | 17.37 | ||
High | 64.45 | 150.92 | 17.71 | ||
Low | 63.31 | 147.74 | 17.28 | ||
Last | 64.25 | 148.71 | 17.57 | ||
Change | +0.90 | -1.17 | +0.12 | ||
% Change | +1.42% | -0.78% | +0.69% | ||
Volume | 567,100 | 250,300 | 3,998,600 | ||
20-Day Average Volume | 866,205 | 318,400 | 3,328,100 | ||
Previous Close | 63.35 | 149.88 | 17.45 | ||
Industry | Medical Products | Medical Products | Medical Products | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 65.61 | 144.64 | 17.67 | ||
20-Day Raw Stochastic | 17.18% | 78.87% | 32.48% | ||
20-Day Relative Strength | 43.75% | 47.80% | 42.69% | ||
Weighted Alpha | -29.62 | +25.83 | -17.62 | ||
Today's Opinion | 100% Sell | 56% Sell | 56% Sell | ||
Previous Opinion | 100% Sell | 56% Sell | 56% Sell | ||
Last Month's Opinion | 88% Sell | 24% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -1.50% since 03/19/25 | -1.68% since 03/19/25 | +3.35% since 03/19/25 | ||
Low | 63.03 on 03/25/25 | 142.83 on 03/21/25 | 16.49 on 03/21/25 | ||
High | 65.21 on 03/20/25 | 152.06 on 03/25/25 | 17.74 on 03/25/25 | ||
1-Month | |||||
%Chg | -1.05% since 02/26/25 | -3.60% since 02/26/25 | -15.24% since 02/26/25 | ||
Low | 63.03 on 03/25/25 | 126.95 on 03/10/25 | 16.06 on 03/13/25 | ||
High | 70.13 on 03/10/25 | 154.54 on 02/27/25 | 20.72 on 02/27/25 | ||
3-Month | |||||
%Chg | -18.52% since 12/26/24 | -4.95% since 12/26/24 | -9.15% since 12/26/24 | ||
Low | 58.80 on 02/10/25 | 126.95 on 03/10/25 | 16.06 on 03/13/25 | ||
High | 82.25 on 01/15/25 | 175.51 on 01/27/25 | 22.68 on 02/06/25 | ||
6-Month | |||||
%Chg | -16.07% since 09/26/24 | -14.77% since 09/26/24 | -8.73% since 09/26/24 | ||
Low | 58.80 on 02/10/25 | 126.95 on 03/10/25 | 16.06 on 03/13/25 | ||
High | 94.99 on 11/12/24 | 196.26 on 11/13/24 | 23.00 on 10/31/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,227,727 | 3,646,219 | 3,025,343 | ||
Shares Outstanding, K | 50,237 | 24,519 | 172,188 | ||
Annual Sales | 1,309,060,000 | 2,382,050,000 | 2,510,600,000 | ||
Annual Net Income | 117,560,000 | -117,690,000 | -1,118,600,000 | ||
Last Quarter Sales | 348,540,000 | 629,800,000 | 652,900,000 | ||
Last Quarter Net Income | 37,490,000 | -23,830,000 | 1,200,000 | ||
60-Month Beta | 0.43 | 0.73 | 1.33 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.19 on 02/06/25 | 2.11 on 02/27/25 | 0.24 on 02/05/25 | ||
Latest Earnings Date | 05/08/25 | 05/06/25 | 05/07/25 | ||
Most Recent Dividend | N/A | 1.500 on 03/18/02 | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 14.98 | 31.42 | 23.90 |